GLYCERIN, LIDOCAINE

N/A

Manufactured by Haleon US Holdings LLC

25,225 FDA adverse event reports analyzed

Last updated: 2026-04-14

About GLYCERIN, LIDOCAINE

GLYCERIN, LIDOCAINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Haleon US Holdings LLC. The most commonly reported adverse reactions for GLYCERIN, LIDOCAINE include DRUG INEFFECTIVE, ORAL HERPES, CONDITION AGGRAVATED, DRUG ADMINISTRATION ERROR, INCORRECT DRUG ADMINISTRATION DURATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GLYCERIN, LIDOCAINE.

Top Adverse Reactions

DRUG INEFFECTIVE6,634 reports
ORAL HERPES2,413 reports
CONDITION AGGRAVATED1,891 reports
DRUG ADMINISTRATION ERROR1,779 reports
INCORRECT DRUG ADMINISTRATION DURATION803 reports
HERPES SIMPLEX706 reports
INCORRECT PRODUCT ADMINISTRATION DURATION611 reports
LIP SWELLING538 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS538 reports
PRODUCT QUALITY ISSUE537 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION491 reports
APPLICATION SITE PAIN441 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION388 reports
PRODUCT COMPLAINT366 reports
HYPERSENSITIVITY310 reports
SWELLING FACE283 reports
APPLICATION SITE ERYTHEMA245 reports
APPLICATION SITE IRRITATION229 reports
PRODUCT USE IN UNAPPROVED INDICATION215 reports
APPLICATION SITE SWELLING208 reports
PRODUCT USE ISSUE187 reports
EXPIRED PRODUCT ADMINISTERED171 reports
APPLICATION SITE SCAB165 reports
ORAL DISCOMFORT152 reports
INTENTIONAL DRUG MISUSE151 reports
RASH150 reports
CHEILITIS143 reports
LIP PAIN143 reports
PAIN125 reports
LIP DRY124 reports
APPLICATION SITE REACTION122 reports
ERYTHEMA122 reports
PRURITUS112 reports
BLISTER111 reports
OFF LABEL USE104 reports
APPLICATION SITE SCAR101 reports
BURNING SENSATION100 reports
CHAPPED LIPS100 reports
DRUG EFFECTIVE FOR UNAPPROVED INDICATION99 reports
ACCIDENTAL EXPOSURE TO PRODUCT91 reports
LIP BLISTER90 reports
APPLICATION SITE HAEMORRHAGE87 reports
APPLICATION SITE PARAESTHESIA87 reports
APPLICATION SITE VESICLES87 reports
LIP HAEMORRHAGE87 reports
APPLICATION SITE PRURITUS86 reports
SCAB83 reports
APPLICATION SITE DISCOLOURATION81 reports
DRUG HYPERSENSITIVITY80 reports
HEADACHE79 reports
SCAR78 reports
APPLICATION SITE DRYNESS68 reports
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE66 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION62 reports
PARAESTHESIA ORAL62 reports
HYPOAESTHESIA ORAL61 reports
PARAESTHESIA61 reports
DIZZINESS60 reports
HYPOAESTHESIA58 reports
DIARRHOEA57 reports
DYSPNOEA57 reports
FATIGUE57 reports
LIP DISORDER57 reports
NAUSEA57 reports
ORAL PAIN57 reports
DRUG EFFECT LESS THAN EXPECTED50 reports
LIP EXFOLIATION48 reports
VOMITING48 reports
APPLICATION SITE BLEEDING45 reports
APPLICATION SITE BURN44 reports
THERAPEUTIC PRODUCT EFFECT DELAYED44 reports
SWELLING42 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE42 reports
URTICARIA41 reports
ASTHENIA39 reports
CONSTIPATION38 reports
THERAPEUTIC RESPONSE UNEXPECTED38 reports
ADVERSE DRUG REACTION37 reports
APPLICATION SITE EXFOLIATION37 reports
LIP DISCOLOURATION37 reports
SKIN LACERATION37 reports
ARTHRALGIA35 reports
DRY SKIN35 reports
ADVERSE EVENT34 reports
RHINORRHOEA34 reports
WEIGHT DECREASED33 reports
APPLICATION SITE INFECTION32 reports
CHILLS32 reports
DRUG ADMINISTERED AT INAPPROPRIATE SITE32 reports
GAIT DISTURBANCE32 reports
PRODUCT PACKAGE ASSOCIATED INJURY32 reports
DRUG EFFECT DELAYED30 reports
EAR PAIN30 reports
IMPAIRED HEALING30 reports
ABDOMINAL DISCOMFORT29 reports
ABDOMINAL PAIN29 reports
BACK PAIN29 reports
DYSPHAGIA29 reports
NONSPECIFIC REACTION29 reports
ANAPHYLACTIC REACTION28 reports

Report Outcomes

Out of 13,854 classified reports for GLYCERIN, LIDOCAINE:

Serious 1.8%Non-Serious 98.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female9,005 (74.6%)
Male3,040 (25.2%)
Unknown18 (0.1%)

Reports by Age

Age 55200 reports
Age 65182 reports
Age 50170 reports
Age 52170 reports
Age 56167 reports
Age 35164 reports
Age 58163 reports
Age 64163 reports
Age 60162 reports
Age 59160 reports
Age 40157 reports
Age 70154 reports
Age 51152 reports
Age 72152 reports
Age 27151 reports
Age 54151 reports
Age 30150 reports
Age 62150 reports
Age 38149 reports
Age 42148 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GLYCERIN, LIDOCAINE?

This profile reflects 25,225 FDA FAERS reports that mention GLYCERIN, LIDOCAINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GLYCERIN, LIDOCAINE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, ORAL HERPES, CONDITION AGGRAVATED, DRUG ADMINISTRATION ERROR, INCORRECT DRUG ADMINISTRATION DURATION, HERPES SIMPLEX. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GLYCERIN, LIDOCAINE?

Labeling and FAERS entries often list Haleon US Holdings LLC in connection with GLYCERIN, LIDOCAINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.